Trial intelligence / Profile preview

Fluomizin vs Canesten in Vulvovaginal Candidiasis

NCT02242695Phase 4Completed

Sponsor
Medinova AG
Start
Nov 2014
Primary completion
Dec 2015
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of dequalinium in vulvovaginal candidiasis (VVC), sponsored by Medinova AG. Started Nov 2014; status: completed.

02

Drugs

dequalinium
03

Conditions

vulvovaginal candidiasis (VVC)

Beyond the preview

Go deeper on NCT02242695.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02242695.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call